PL2068901T3 - Zastosowanie hydroksytyrozolu do zmniejszenia ilości kwasu mlekowego w osoczu - Google Patents

Zastosowanie hydroksytyrozolu do zmniejszenia ilości kwasu mlekowego w osoczu

Info

Publication number
PL2068901T3
PL2068901T3 PL07818713T PL07818713T PL2068901T3 PL 2068901 T3 PL2068901 T3 PL 2068901T3 PL 07818713 T PL07818713 T PL 07818713T PL 07818713 T PL07818713 T PL 07818713T PL 2068901 T3 PL2068901 T3 PL 2068901T3
Authority
PL
Poland
Prior art keywords
hydroxytyrosol
plasma
reduce
amount
lactic acid
Prior art date
Application number
PL07818713T
Other languages
English (en)
Inventor
Saskia Johannes Rietjens
Aalt Bast
Guido Rembertus Michiel Marie Haenen
Van Der Lucas Cyril Gerard Heyden
Original Assignee
Dsm Ip Assets Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dsm Ip Assets Bv filed Critical Dsm Ip Assets Bv
Publication of PL2068901T3 publication Critical patent/PL2068901T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/63—Oleaceae (Olive family), e.g. jasmine, lilac or ash tree
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K10/00—Animal feeding-stuffs
    • A23K10/30—Animal feeding-stuffs from material of plant origin, e.g. roots, seeds or hay; from material of fungal origin, e.g. mushrooms
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Mycology (AREA)
  • Botany (AREA)
  • Polymers & Plastics (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Nutrition Science (AREA)
  • Zoology (AREA)
  • Animal Husbandry (AREA)
  • Physiology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Pain & Pain Management (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Neurology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Fodder In General (AREA)
PL07818713T 2006-10-05 2007-10-05 Zastosowanie hydroksytyrozolu do zmniejszenia ilości kwasu mlekowego w osoczu PL2068901T3 (pl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP06121809 2006-10-05
EP06121812 2006-10-05
PCT/EP2007/008636 WO2008040550A2 (en) 2006-10-05 2007-10-05 Olive extracts for promoting muscle health
EP07818713.5A EP2068901B1 (en) 2006-10-05 2007-10-05 Use of hydroxytyrosol to reduce the amount of lactic acid in plasma

Publications (1)

Publication Number Publication Date
PL2068901T3 true PL2068901T3 (pl) 2019-05-31

Family

ID=39268835

Family Applications (1)

Application Number Title Priority Date Filing Date
PL07818713T PL2068901T3 (pl) 2006-10-05 2007-10-05 Zastosowanie hydroksytyrozolu do zmniejszenia ilości kwasu mlekowego w osoczu

Country Status (8)

Country Link
US (2) US20110052750A1 (pl)
EP (1) EP2068901B1 (pl)
JP (1) JP5315521B2 (pl)
KR (1) KR20090064398A (pl)
ES (1) ES2712706T3 (pl)
PL (1) PL2068901T3 (pl)
TR (1) TR201902588T4 (pl)
WO (1) WO2008040550A2 (pl)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2009161459A (ja) * 2007-12-28 2009-07-23 Kao Corp 持久力向上剤
US20110112201A1 (en) * 2008-04-17 2011-05-12 Jiankang Liu Hydroxytyrosol benefits mitochondria
EP2501371A4 (en) * 2009-10-07 2013-07-31 Dsm Ip Assets Bv USE OF HYDROXYTYROSOL FOR IMPROVED MUSCLE DIFFERENTIATION
JP6288757B2 (ja) * 2013-08-23 2018-03-07 京都府公立大学法人 運動機能性向上剤
JP2016199536A (ja) * 2015-04-07 2016-12-01 株式会社ニュートリション・アクト 筋肉増強およびメタボリックシンドローム改善ならびにｑｏｌ改善のための組成物
BR112021019790A2 (pt) * 2019-05-13 2021-12-07 Nestle Sa Composições e métodos que usam uma combinação de cálcio e ao menos um dentre oleuropeína ou metabólito da mesma
JP7742026B2 (ja) 2020-04-03 2025-09-19 三菱瓦斯化学株式会社 筋肉増強剤
US12576060B2 (en) 2020-06-23 2026-03-17 Laila Nutra Private Limited Water soluble 3-O-acetyl-11-keto-β-boswellic acid and metal ion compositions, process for their preparation and uses thereof
EP4525885A1 (en) * 2022-05-18 2025-03-26 Société des Produits Nestlé S.A. Compositions comprising a combination of caffeine and oleuropein or a metabolite thereof and their use for improving muscle function
CN119072318A (zh) * 2022-05-18 2024-12-03 雀巢产品有限公司 包含肌酸和橄榄苦苷或其代谢物的组合的组合物及其用于改善肌肉功能的用途

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58146241A (ja) * 1982-02-26 1983-08-31 Nippon Oil & Fats Co Ltd チユ−インガム
US6358542B2 (en) * 1999-12-20 2002-03-19 Usana, Inc. Antioxidant compositions extracted from olives and olive by-products
US6399116B1 (en) * 2000-04-28 2002-06-04 Rulin Xiu Rhodiola and used thereof
US7713569B2 (en) * 2000-09-01 2010-05-11 Creagri, Inc. Hydroxytyrosol-rich composition from olive vegetation water and method of use thereof
JP2002153238A (ja) * 2000-11-21 2002-05-28 Nippon Shinyaku Co Ltd 食品、飼料及び医薬組成物
EP1429602B1 (en) * 2001-08-31 2009-12-16 Rutgers, The State University Of New Jersey Methods for treating disorders using plant extracts
WO2003082259A1 (en) * 2002-04-03 2003-10-09 Puleva Biotech, S.A. Natural phenolic products and derivatives thereof for protection against neurodegenerative diseases
AU2004249023A1 (en) * 2003-06-19 2004-12-29 Suntory Limited Movement physiology improver
JP2005058115A (ja) * 2003-08-15 2005-03-10 Kinka:Kk 風味調味料およびその製造方法
GB2415136A (en) * 2004-06-17 2005-12-21 Natraceutical Sa Obtaining olive polyphenol concentrate from a by-product of olive oil extraction using membrane separation techniques
CN101060794B (zh) * 2004-11-16 2012-03-07 帝斯曼知识产权资产管理有限公司 抗氧化剂化合物用于肌肉复原的用途

Also Published As

Publication number Publication date
ES2712706T3 (es) 2019-05-14
WO2008040550A2 (en) 2008-04-10
JP5315521B2 (ja) 2013-10-16
KR20090064398A (ko) 2009-06-18
US20110052750A1 (en) 2011-03-03
US20130330431A1 (en) 2013-12-12
EP2068901B1 (en) 2018-11-21
TR201902588T4 (tr) 2019-03-21
EP2068901A2 (en) 2009-06-17
JP2010505784A (ja) 2010-02-25
WO2008040550A3 (en) 2008-06-26

Similar Documents

Publication Publication Date Title
IL249941A0 (en) Spiro-oxaindole substances and medical preparations containing them
PL2068901T3 (pl) Zastosowanie hydroksytyrozolu do zmniejszenia ilości kwasu mlekowego w osoczu
IL212801A (en) Lipids and drug transfer compounds
SI2137141T1 (sl) Arilamidi bifenil-4-il-sulfonske kisline in njihova uporaba kot terapevtska sredstva
IL209073A0 (en) Liquid cleaning compositions and manufacture
GB0703966D0 (en) Improvements in or relating to medicinal compositions
EP2268281A4 (en) THIENOPYRROLES AND PYRROLOTHIAZOLES AS NEW THERAPEUTIC AGENTS
GB0703967D0 (en) Improvements in or relating to medicinal compositions
GB0820877D0 (en) Improvements in or relating to medicament dispensers
IL212672A (en) Cycloandesdepsipeptide compounds and their use in drug production
ZA201102211B (en) Improvements in or relating to the management of e-tickets
GB0620861D0 (en) Improvements in or relating to stairlifts
GB201104566D0 (en) Ferric phosphate based composition and use thereof
GB0800457D0 (en) Improvements in or relating to inhalers
EP2039340A4 (en) COMPOSITION FOR CLEANING THE SKIN
GB0703933D0 (en) Improvements in or relating to medicinal compositions
IL195817A0 (en) Use of 2-benzoyl-imidazopyridines in therapeutics
IL204668A0 (en) Use of sulfonyl - substituted 2 - sulfonylaminobenzoic acid n - phenylamides in the treatment of pain
GB0822486D0 (en) Compounds for use in the treatment of pain
GB0902537D0 (en) Improvememts in or relating to the creation of curved forms
EP2255814A4 (en) MEDIUM FOR INCREASING THE HYALURONIC ACID
GB0709223D0 (en) Improvements in or relating to core stabilization
IL213711A0 (en) Pharmaceuticl formulation of nanonised fenofibrate
GB0720400D0 (en) Improvements in or relating to the preparation of beverages
GB0725347D0 (en) Improvements in or relating to pipeine pigs